Related Experiment Video
Updated: Sep 19, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
[Disseminated fungal infections in neonates--risk factors, treatment and course]
T G Abrahamsen1, P Gaustad, S Sund
1Barneklinikken, Rikshospitalet, Oslo.
Insights
Disseminated Candida albicans infections occurred in 9% of premature infants with abdominal disease. Amphotericin B showed promise, while fluconazole had poor outcomes in this small study.
Area of Science:
- Neonatal Medicine
- Mycology
- Infectious Diseases
Context:
- Candida albicans infections pose a significant threat to vulnerable newborns.
- Intra-abdominal diseases increase the risk of systemic fungal infections in neonates.
- This study examines a cohort of infants with disseminated candidiasis during 1990/91.
Purpose:
- To report the incidence and outcomes of disseminated Candida albicans infections in neonates with intra-abdominal disease.
- To identify risk factors associated with these infections in premature infants.
- To evaluate the efficacy of antifungal treatments, specifically amphotericin B and fluconazole.
Summary:
- Eight premature and one mature infant with intra-abdominal disease developed disseminated Candida albicans infections (9% incidence in premature neonates).
- Commonly observed risk factors included respirator therapy, broad-spectrum antibiotics, parenteral nutrition, and central intravascular catheters.
- Four patients survived; three of five treated with amphotericin B survived, whereas two treated with fluconazole died. One patient survived without therapy, and another was diagnosed post-mortem.
Impact:
- Highlights the high-risk nature of disseminated candidiasis in neonates with abdominal conditions.
- Suggests amphotericin B may be a more effective treatment option than fluconazole in this population.
- Emphasizes the critical need for accurate fungal diagnostics and interdisciplinary collaboration for optimal patient management.
Abstract:
During 10 1/2 months in 1990/91 eight premature babies and one mature baby with an intra-abdominal disease had disseminated Candida albicans infections. The incidence in premature newborns was 9% (8/92 patients). Risk factors such as respirator therapy, the use of broad spectrum antibiotics, supplemental parenteral nutrition and central intravascular catheters were frequently seen. Four patients survived the fungal infection. These included three of five babies treated with amphotericin B 0.5 mg/kg/day. Two patients who received fluconazole 3 mg/kg/day died after three days. In one patient the diagnosis was obtained post-mortem, and one patient with possible fungemia survived without therapy. The treatment of these patients depends on optimal fungal cultures and good co-operation between paediatricians and microbiologists.
Related Concept Videos
Fungal Phylum Microsporidia
Development of Human Microbiota
Development of the Oral Microbiota
Rocky Mountain Spotted Fever
Cryptococcal Meningitis
Antifungal Agents

